Dakula, Norma M.
HRN: 24-03-98 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/26/2026
MUPIROCIN 2%, 15G (TUBE)
07/26/2026
08/02/2026
TOPICAL
2%
BID
Sacral Ulcer
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: